The Patent Finder

Terms ending in 2027

Ambrx, Inc.

Every in-force patent on Ambrx, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,175,083Novel Antigen-Binding Polypeptides and Their Uses
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 7,632,924Novel Antigen-Binding Polypeptides and Their Uses
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 7,632,823Compositions of Trna and Uses Thereof
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 7,919,591Modified Human Plasma Polypeptide or FC Scaffolds and Their Uses
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 9,868,972Hybrid Suppressor Trna for Vertebrate Cells
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 8,008,456Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
US 8,906,676Modified Human Four Helical Bundle Polypeptides And Their Uses
In force
 · High confidence
Ambrx, Inc.In forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited